Adicet Bio, Inc Alternatives & Competitors

12 companies similar to Adicet Bio, Inc — A biotechnology company discovering and developing first-in-class allogeneic gam...

Cullinan Therapeutics

Science That Moves

131 Post Ipo Equity $669.70M

Cambridge, United States

Biopharma Biotechnology +1

Compare

Autolus Therapeutics

Focused on the development of precisely targeted, controlled & highly active T cell therap...

763 Post Ipo Equity $1.07B

London, United Kingdom

Biopharma Biotechnology +1

Cartesian Therapeutics

Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune dis...

4 IPO $132.00M

Biotechnology

Repertoire Immune Medicines

Repertoire is a biotechnology company creating a new category of immune medicines for canc...

86 Series B $189.00M

Cambridge, United States

Biotechnology Health and Wellness +1

Track all Adicet Bio, Inc competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Asylia Therapeutics

Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...

1 Series A $14.50M

Biotechnology Health Care +1

Fate Therapeutics Inc.

Transforming the lives of patients with autoimmune diseases and cancer.

227 Unknown $1.24B

San Diego, United States

Biotechnology Health Care +1

Gracell Biotechnologies

A Member of the AstraZeneca Group

33 Acquired $1.29B

Shanghai, China

Biotechnology Health Care

Kernal Biologics

KernalBio creates mRNA therapies that instruct specific cells on how to make their own med...

22 Series A $26.82M

Cambridge, United States

Biotechnology Health and Wellness +1

Immunocore

Science to Transform Lives

603 IPO $975.60M

Abingdon, United Kingdom

Biotechnology Health Care +1

Roivant

Reinventing Biopharma

244 Unknown $5.01B

New York, United States

Biopharma Biotechnology +2

Treeline

Making medicines at the highest level

172 Series A $473.27M

Watertown, United States

Biotechnology Health Care +1

Granza Bio

Reprogramming Immunity for Target-Specific Medicines

7 Seed $7.64M

Biopharma Biotechnology +1

About Adicet Bio, Inc

A biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Services

Gamma Delta T Cell Therapies, Allogeneic Gamma Delta CAR T Cell Therapy, Cancer and Autoimmune Disease Research

Target Customers

Patients with Autoimmune Diseases, Cancer Patients, Healthcare Providers, Biotech Investors

Taxonomy

Cell Therapy, Gamma-delta T Cells, Allogeneic Therapies, CAR T Cell Therapies, Cancer Treatment, Autoimmune Diseases, Immune Reset, Solid Tumors, Tumor Targeting, Innate Immune Response, Adaptive Immune Response, Off-the-shelf Therapies, Biopharma Innovation, Chimeric Antigen Receptors

Business Model

B2B, B2C, B2D

Revenue Model

Licensing, Performance Based

Frequently Asked Questions

Top alternatives to Adicet Bio, Inc include Cullinan Therapeutics, Autolus Therapeutics, Cartesian Therapeutics, Repertoire Immune Medicines, Asylia Therapeutics. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Adicet Bio, Inc based on industry overlap, target customers, and business model.

A biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Don't just read about them. Follow them.

BounceWatch watches Adicet Bio, Inc and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Adicet Bio, Inc Profile Cullinan Therapeutics Alternatives Autolus Therapeutics Alternatives Cartesian Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Adicet Bio, Inc on 9 Jun 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.